Literature DB >> 9934970

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group.

R J Sokol1, P R Durie.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 9934970     DOI： 10.1097/00005176-199900001-00001

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  37 in total

1.  Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.

Authors:  Paul Beringer; Kitty My Tu Huynh; Jane Kriengkauykiat; Luke Bi; Nils Hoem; Stan Louie; Emily Han; Thao Nguyen; Donald Hsu; Purush A Rao; Bertrand Shapiro; Mark Gill
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 2.  The role of abdominal ultrasound in the diagnosis, staging and management of cystic fibrosis liver disease.

Authors:  Louise Stewart
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

3.  Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.

Authors:  David G Perdue; Oliver W Cass; Carlos Milla; Jordan Dunitz; Jose Jessurun; Harvey L Sharp; Sarah J Schwarzenberg
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

Review 4.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

5.  Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series.

Authors:  B Linnane; M R Oliver; P J Robinson
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

6.  Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.

Authors:  Christopher Koh; Sasan Sakiani; Pallavi Surana; Xiongce Zhao; Jason Eccleston; David E Kleiner; David Herion; T Jake Liang; Jay H Hoofnagle; Milica Chernick; Theo Heller
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

7.  Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study.

Authors:  Marilyn J Siegel; A Jay Freeman; Wen Ye; Joseph J Palermo; Jean P Molleston; Shruti M Paranjape; Janis Stoll; Daniel H Leung; Prakash Masand; Boaz Karmazyn; Roger Harned; Simon C Ling; Oscar M Navarro; Wikrom Karnsakul; Adina Alazraki; Sarah Jane Schwarzenberg; Frank Glen Seidel; Alex Towbin; Estella M Alonso; Jennifer L Nicholas; Karen F Murray; Randolph K Otto; Averell H Sherker; John C Magee; Michael R Narkewicz
Journal:  J Pediatr       Date:  2020-02-12       Impact factor: 4.406

8.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

9.  Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes.

Authors:  Dongning He; Teresa W Wilborn; Josie L Falany; Li Li; Charles N Falany
Journal:  Biochim Biophys Acta       Date:  2008-09-11

10.  Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis.

Authors:  Daniel H Leung; Wen Ye; Jean P Molleston; Alexander Weymann; Simon Ling; Shruti M Paranjape; Rene Romero; Sara Jane Schwarzenberg; Joseph Palermo; Estella M Alonso; Karen F Murray; Bruce C Marshall; Averell H Sherker; Marilyn J Siegel; Rajesh Krishnamurthy; Roger Harned; Boaz Karmazyn; John C Magee; Michael R Narkewicz
Journal:  J Pediatr       Date:  2015-08-05       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.